BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20860477)

  • 1. Managing invasive fungal infection in hematopoietic stem-cell transplantation.
    Sinkó J; Bryan J
    Future Microbiol; 2010 Sep; 5(9):1309-14. PubMed ID: 20860477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
    Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
    Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
    Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
    Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint.
    Bow EJ
    Mycopathologia; 2009 Dec; 168(6):283-97. PubMed ID: 19343534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal agents in hematopoietic stem cell transplantation.
    Parameswaran GI; Segal BH; Almyroudis NG
    Curr Pharm Des; 2008; 14(20):2011-21. PubMed ID: 18691111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
    Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
    BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
    Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
    Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
    Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.
    Pagano L; Caira M; Nosari A; Cattaneo C; Fanci R; Bonini A; Vianelli N; Garzia MG; Mancinelli M; Tosti ME; Tumbarello M; Viale P; Aversa F; Rossi G;
    Haematologica; 2011 Sep; 96(9):1366-70. PubMed ID: 21565903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of hematopoietic stem transplantation: Fungal infections.
    Omrani AS; Almaghrabi RS
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):239-244. PubMed ID: 28636889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
    Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N; Pedicone L; Patino H; Durrant S
    N Engl J Med; 2007 Jan; 356(4):335-47. PubMed ID: 17251530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
    Camps IR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
    Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis: why, what and how?
    Lyon S
    Future Microbiol; 2016; 11(1):11-5. PubMed ID: 26674314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.